Parth Narendran: key facts
- Kind of voice
- Academic
- Role
- Professor of Diabetes Medicine at the University of Birmingham
- Quoted on
- Diabetes
- Press citations held
- 3
- Most recently quoted
- 10 Sept 2026
“We are extremely grateful to all the families who have participated in the study and generously given their time to help understand how a UK-wide screening programme could be developed. Together with Diabetes UK, Breakthrough T1D and the National Institute for Health and Care Research, we are working towards a future where type 1 diabetes can be detected in a timely manner, and families appropriately supported and treated with medicines to delay the need for insulin.”
What Parth Narendran has said
“This is a landmark study for the UK, it shows for the first time that we can identify those people at an early stage, prevent emergency diagnoses. It's giving families time to prepare. Once they're on insulin, they'll just flow naturally, with the same healthcare team, into the normal type one clinic.”
professor of diabetes medicine and honorary consultant physician at the University of Birmingham · Diabetes · 10 Sept 2026 · Large NHS study provides ‘blueprint’ for type 1 diabetes screening in children ↗
“Teplizumab essentially trains the immune system to stop attacking the beta cells in the pancreas, allowing the pancreas to produce insulin without interference. This can allow eligible patients to live normal lives, delaying the need for insulin injections and the full weight of the disease's daily management by up to three years.”
professor of diabetes medicine at the University of Birmingham and The Queen Elizabeth Hospital Birmingham · Diabetes · 8 Sept 2026 · Breakthrough drug slows onset of type 1 diabetes ↗
Where Parth Narendran has been quoted
- National childhood type 1 diabetes screening is effective and could prevent thousands of emergency diagnosesdiabetestimes.co.uk · 10 Sept 2026
- Large NHS study provides ‘blueprint’ for type 1 diabetes screening in childrenpulsetoday.co.uk · 10 Sept 2026
- Breakthrough drug slows onset of type 1 diabetesaol.com · 8 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Sept 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.